FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998875823> ?p ?o ?g. }

• W1998875823 endingPage "982" @default.
• W1998875823 startingPage "972" @default.
• W1998875823 abstract "To evaluate the safety and efficacy of aerosolized ceftazidime for prevention of ventilator-associated pneumonia (VAP) and to evaluate the effects of the drug on the proinflammatory response.Prospective, randomized, double-blind, placebo-controlled clinical trial.University teaching hospital.Forty critically ill trauma patients at high risk for VAP Intervention. Within 48 hours of admission to the intensive care unit (ICU), patients were randomly assigned to receive aerosolized ceftazidime 250 mg every 12 hours or placebo (normal saline) for up to 7 days. Bronchoalveolar concentrations of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1beta, IL-6, and IL-8 were determined at baseline and the end of therapy (days 4-7).The frequency of VAP in patients receiving aerosolized ceftazidime was 73% lower than that in patients receiving placebo at ICU day 14 (15% vs 55%, p = 0.021), and 54% lower for the entire ICU stay (30% vs 65%, p = 0.022). No clinically significant changes in bacterial culture and sensitivity patterns were observed. No adverse events from aerosolized ceftazidime were reported. Pulmonary TNF-alpha, IL-beta, and IL-8 concentrations were attenuated in the ceftazidime group compared with those in the placebo group (p < 0.001, p = 0.02, and p = 0.003). The frequency of VAP was related directly to changes in TNF-alpha and IL-beta (p < 0.001, p = 0.02).Aerosolized ceftazidime decreased the frequency of VAP in critically ill trauma patients, without adversely affecting ICU flora. Aerosolized ceftazidime also may attenuate the proinflammatory response in the lung." @default.
• W1998875823 created "2016-06-24" @default.
• W1998875823 creator A5008477406 @default.
• W1998875823 creator A5014291446 @default.
• W1998875823 creator A5031320162 @default.
• W1998875823 creator A5064797781 @default.
• W1998875823 creator A5089053265 @default.
• W1998875823 creator A5091280671 @default.
• W1998875823 date "2002-08-01" @default.
• W1998875823 modified "2023-10-16" @default.
• W1998875823 title "Aerosolized Ceftazidime for Prevention of Ventilator-Associated Pneumonia and Drug Effects on the Proinflammatory Response in Critically Ill Trauma Patients" @default.
• W1998875823 cites W140892492 @default.
• W1998875823 cites W1792293914 @default.
• W1998875823 cites W1964823995 @default.
• W1998875823 cites W1966375310 @default.
• W1998875823 cites W1972811743 @default.
• W1998875823 cites W1974845747 @default.
• W1998875823 cites W1977885856 @default.
• W1998875823 cites W1978970048 @default.
• W1998875823 cites W1989051941 @default.
• W1998875823 cites W1990423362 @default.
• W1998875823 cites W1993136878 @default.
• W1998875823 cites W1994332094 @default.
• W1998875823 cites W2012906489 @default.
• W1998875823 cites W2025801951 @default.
• W1998875823 cites W2028033325 @default.
• W1998875823 cites W2030750548 @default.
• W1998875823 cites W2040388340 @default.
• W1998875823 cites W2042157055 @default.
• W1998875823 cites W2056299425 @default.
• W1998875823 cites W2059315107 @default.
• W1998875823 cites W2064605932 @default.
• W1998875823 cites W2064610856 @default.
• W1998875823 cites W2067804184 @default.
• W1998875823 cites W2069146079 @default.
• W1998875823 cites W2070116031 @default.
• W1998875823 cites W2088193634 @default.
• W1998875823 cites W2103998436 @default.
• W1998875823 cites W2129707656 @default.
• W1998875823 cites W2136140396 @default.
• W1998875823 cites W2142470582 @default.
• W1998875823 cites W2151629261 @default.
• W1998875823 cites W2153354364 @default.
• W1998875823 cites W2156920884 @default.
• W1998875823 cites W2167579208 @default.
• W1998875823 cites W2171893056 @default.
• W1998875823 cites W2293384288 @default.
• W1998875823 cites W2324420634 @default.
• W1998875823 cites W2325712546 @default.
• W1998875823 cites W2329782666 @default.
• W1998875823 cites W2768146862 @default.
• W1998875823 cites W2917862595 @default.
• W1998875823 cites W2964425872 @default.
• W1998875823 cites W4244614789 @default.
• W1998875823 cites W4245771622 @default.
• W1998875823 cites W4293108385 @default.
• W1998875823 cites W4293242440 @default.
• W1998875823 doi "https://doi.org/10.1592/phco.22.12.972.33596" @default.
• W1998875823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12173800" @default.
• W1998875823 hasPublicationYear "2002" @default.
• W1998875823 type Work @default.
• W1998875823 sameAs 1998875823 @default.
• W1998875823 citedByCount "69" @default.
• W1998875823 countsByYear W19988758232012 @default.
• W1998875823 countsByYear W19988758232013 @default.
• W1998875823 countsByYear W19988758232014 @default.
• W1998875823 countsByYear W19988758232015 @default.
• W1998875823 countsByYear W19988758232016 @default.
• W1998875823 countsByYear W19988758232017 @default.
• W1998875823 countsByYear W19988758232018 @default.
• W1998875823 countsByYear W19988758232019 @default.
• W1998875823 countsByYear W19988758232020 @default.
• W1998875823 countsByYear W19988758232021 @default.
• W1998875823 countsByYear W19988758232022 @default.
• W1998875823 countsByYear W19988758232023 @default.
• W1998875823 crossrefType "journal-article" @default.
• W1998875823 hasAuthorship W1998875823A5008477406 @default.
• W1998875823 hasAuthorship W1998875823A5014291446 @default.
• W1998875823 hasAuthorship W1998875823A5031320162 @default.
• W1998875823 hasAuthorship W1998875823A5064797781 @default.
• W1998875823 hasAuthorship W1998875823A5089053265 @default.
• W1998875823 hasAuthorship W1998875823A5091280671 @default.
• W1998875823 hasConcept C126322002 @default.
• W1998875823 hasConcept C142724271 @default.
• W1998875823 hasConcept C164027704 @default.
• W1998875823 hasConcept C177713679 @default.
• W1998875823 hasConcept C204787440 @default.
• W1998875823 hasConcept C27081682 @default.
• W1998875823 hasConcept C2776376669 @default.
• W1998875823 hasConcept C2776914184 @default.
• W1998875823 hasConcept C2776968632 @default.
• W1998875823 hasConcept C2777184939 @default.
• W1998875823 hasConcept C2777637488 @default.
• W1998875823 hasConcept C2777714996 @default.
• W1998875823 hasConcept C2777914695 @default.
• W1998875823 hasConcept C2777961210 @default.
• W1998875823 hasConcept C2987404301 @default.
• W1998875823 hasConcept C42219234 @default.

• next